Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. Officials Study Japan for Lessons on Imports (Japan)

This article was originally published in PharmAsia News

Executive Summary

The growing concern about the safety of imported product, particularly those from China, has U.S. officials looking for new strategies to ensure the health of American consumers. Recently, Japan's import-screening procedures were cited by the House Committee on Energy and Commerce as a possible example of a system the U.S. should adopt. According to Japan's Health Ministry, Japan tests about 10 percent of all food imports, compared to less than 1 percent in the United States. Japan has also instituted an effective policy specifically used for Chinese-produced spinach. As part of the program, Japan certifies certain Chinese spinach producers who meet Japanese standards. These designated producers are then allowed to import to Japan. Although this can lead to higher prices for consumers because of reduced competition, the price kick also works as an incentive for the producers to continue adhering to best practices. The program has been so successful it may be expanded to other products. (Click here for more - May Require Free Registration

You may also be interested in...

Where The COVID Vaccine Trials Stand: A Snapshot Of The Leaders And Rest Of The Field

With some studies about to finish and others on clinical hold, the coronavirus vaccine field approaches an infection point as the US FDA prepares for its first advisory committee on the topic. Our charts and graphics offer a quick look at what stands where.

Neuromodulation Firm Lands €10.5M For Tinnitus Treatment

Funds will be used to expand European sales of the CE-marked Lenire device, scale-up manufacturing and progress US regulatory and reimbursement plans.

Reckitt Spies Opportunity For Global Supplements Business

RB CEO Laxman Narasimhan sees the potential for the company to establish a global supplements business built on the successes it has enjoyed in the US and China. The comments came as RB reported solid growth in the third quarter, despite struggles for its OTC brands.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts